Efficacy & Safety Evaluation of Enobosarm in Combo With Abemaciclib in Treatment of ER+HER2- Metastatic Breast Cancer
Trial details
- Registry ID
- NCT05065411
- Phase
- Phase 3
Drug identity checked against registry records
Also recorded as VERU-024; Verzenio
| Trial | Sponsor | Phase | Status | Primary completion |
|---|---|---|---|---|
| Efficacy & Safety Evaluation of Enobosarm in Combo With Abemaciclib in Treatment of ER+HER2- Metastatic Breast CancerNCT05065411 | VERU | Phase 3 | Terminated | 2023-10-19Actual |
| No regulatory events match this view.This does not mean no FDA events have occurred. |